106 related articles for article (PubMed ID: 26551871)
1. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications.
Parra A; Mallandrich M; Clares B; Egea MA; Espina M; García ML; Calpena AC
Colloids Surf B Biointerfaces; 2015 Dec; 136():935-43. PubMed ID: 26551871
[TBL] [Abstract][Full Text] [Related]
2. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
[TBL] [Abstract][Full Text] [Related]
3. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.
Parra A; Clares B; Rosselló A; Garduño-Ramírez ML; Abrego G; García ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):10-7. PubMed ID: 26826569
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
7. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
Vega E; Gamisans F; García ML; Chauvet A; Lacoulonche F; Egea MA
J Pharm Sci; 2008 Dec; 97(12):5306-17. PubMed ID: 18425815
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
Katara R; Sachdeva S; Majumdar DK
Drug Deliv Transl Res; 2017 Oct; 7(5):632-641. PubMed ID: 28812225
[TBL] [Abstract][Full Text] [Related]
9. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Vega E; Egea MA; Calpena AC; Espina M; García ML
Int J Nanomedicine; 2012; 7():1357-71. PubMed ID: 22457594
[TBL] [Abstract][Full Text] [Related]
10. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
Sánchez-López E; Egea MA; Cano A; Espina M; Calpena AC; Ettcheto M; Camins A; Souto EB; Silva AM; García ML
Colloids Surf B Biointerfaces; 2016 Sep; 145():241-250. PubMed ID: 27187188
[TBL] [Abstract][Full Text] [Related]
11. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study.
Sah AK; Suresh PK; Verma VK
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-9. PubMed ID: 27389068
[TBL] [Abstract][Full Text] [Related]
13. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
14. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
Alvarado HL; Abrego G; Garduño-Ramirez ML; Clares B; Calpena AC; García ML
Nanomedicine; 2015 Apr; 11(3):521-30. PubMed ID: 25659643
[TBL] [Abstract][Full Text] [Related]
15. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies.
Khan N; Ameeduzzafar ; Khanna K; Bhatnagar A; Ahmad FJ; Ali A
Int J Biol Macromol; 2018 Sep; 116():648-663. PubMed ID: 29723623
[TBL] [Abstract][Full Text] [Related]
16. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
Kalam MA; Alshamsan A
Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219
[TBL] [Abstract][Full Text] [Related]
17. Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents.
Dhapare SS; Dash AK
Ther Deliv; 2015 Jan; 6(1):27-39. PubMed ID: 25565439
[TBL] [Abstract][Full Text] [Related]
18. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
[TBL] [Abstract][Full Text] [Related]
19. Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.
Ramos Yacasi GR; García López ML; Espina García M; Parra Coca A; Calpena Campmany AC
Int J Nanomedicine; 2016; 11():4093-106. PubMed ID: 27601897
[TBL] [Abstract][Full Text] [Related]
20. Methyl trypsin loaded poly(D,L-lactide-coglycolide) nanoparticles for contact lens care.
Jimenez N; Galan J; Vallet A; Egea MA; Garcia ML
J Pharm Sci; 2010 Mar; 99(3):1414-26. PubMed ID: 19774659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
